(Q50094209)
Statements
1 reference
Effects of empagliflozin on risk for cardiovascular death and heart failure hospitalization across the spectrum of heart failure risk in the EMPA-REG OUTCOME® trial. (English)
1 reference
Javed Butler
1 reference
Odd Erik Johansen
1 reference
Bernard Zinman
1 reference
David Fitchett
1 reference
Philippe van de Borne
1 reference
John M Lachin
1 reference
Christoph Wanner
1 reference
Hans J Woerle
1 reference
Stefan Hantel
1 reference
Jyothis T George
1 reference
Silvio E Inzucchi
1 reference
EMPA-REG OUTCOME® trial investigators
1 reference
28 August 2017
1 reference
1 reference
39
1 reference
363-370
1 reference
5
1 reference
Identifiers
1 reference
1 reference